MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
Boston Scientific Corporation Market Cap 2011-2026 | BSX
As of April 14, 2026 Boston Scientific Corporation has a market cap of $ 95.2 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Boston Scientific Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113 B | 155 B | 95.8 B | 67.4 B | 61 B | 50.2 B | 60.4 B | 51.7 B | 38.4 B | 32.4 B | 23.5 B | 19.6 B | 18.2 B | 10.3 B | 9.04 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 155 B | 9.04 B | 53.7 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
13.9 B | $ 186.6 | 3.28 % | $ 14 B |  USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
AxoGen
AXGN
|
1.5 B | $ 34.49 | 3.05 % | $ 1.59 B | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
1.2 B | $ 12.72 | 3.25 % | $ 1.72 B | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
7.81 B | $ 292.85 | 1.62 % | $ 8.26 B | USA |
 |
Cytosorbents Corporation
CTSO
|
34.8 M | $ 0.58 | -0.87 % | $ 36.1 M | USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 3.19 | -4.21 % | $ 119 M |  France |
 |
Bruker Corporation
BRKR
|
6.9 K | $ 40.45 | 3.57 % | $ 6.03 K | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
316 M | $ 10.37 | 3.6 % | $ 294 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
175 M | $ 25.33 | 1.52 % | $ 214 M | USA |
 |
IRIDEX Corporation
IRIX
|
16.6 M | $ 1.03 | 0.01 % | $ 17.4 M | USA |
 |
Myomo
MYO
|
33.9 M | $ 0.76 | 3.85 % | $ 31.8 M | USA |
 |
Inogen
INGN
|
160 M | $ 6.45 | - | $ 172 M | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
12.5 B | $ 95.85 | 3.09 % | $ 13 B | USA |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 1.99 | -1.97 % | $ 1.21 M | USA |
 |
Butterfly Network
BFLY
|
766 M | $ 4.43 | 3.62 % | $ 938 M | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
LENSAR
LNSR
|
71.3 M | $ 6.11 | 3.21 % | $ 73.1 M | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 17.8 | 5.01 % | $ 418 M | USA |
 |
Delcath Systems
DCTH
|
326 M | $ 10.78 | 3.16 % | $ 386 M | USA |
 |
Inspire Medical Systems
INSP
|
1.76 B | $ 56.23 | 2.46 % | $ 1.65 B | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 39.57 | 2.89 % | $ 1.23 B | USA |
 |
LivaNova PLC
LIVN
|
3.81 B | $ 65.44 | 1.33 % | $ 3.57 B |  Britain |
 |
Integer Holdings Corporation
ITGR
|
2.98 B | $ 89.11 | 1.57 % | $ 3.1 B | USA |
 |
FONAR Corporation
FONR
|
85.2 M | $ 18.7 | -0.05 % | $ 123 M | USA |
 |
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
48.8 B | $ 78.24 | 0.15 % | $ 45.8 B | USA |